Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Research and Development

Award Notice Posted

Solicitation number
75N95025P00042
Agency
Awarded
to Luminescent Consulting LLC
Set-aside
Woman-Owned Small Business Sole Source

Opportunity facts

Contract number
75N95025P00042 Federal contract award
Place of performance
Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, has awarded a contract (No. 75N95025P00042) to Luminescent Consulting LLC for consulting services related to medical device development under the Blueprint MedTech Initiative. The contract is a woman-owned small business sole source award with a base period of twelve months and two twelve-month option periods, initially funded at $7,500.00 with a potential total contract value of $46,800.00 if all options are exercised. The time and materials/labor hour contract involves a Subject Matter Expert providing consulting services to support the development of translational neurological medical device technologies, including technical guidance and feedback to NIH program leadership on medical device development projects within the Blueprint MedTech initiative portfolio.

Notice text

On December 6, 2024; in response to the requirements of Solicitation 75N95025Q00015, the National Institute on Drug Abuse (NIDA) awarded a Contract No. 75N95025P00042 to Luminescent Consulting LLC as a time and materials/labor hour contract with a base period of twelve months and two twelve-month option periods, plus option quantities. At the time of award, the contract was funded in the not-to-exceed amount of $7,500.00. If all options are exercised, the total contract and obligated amount shall not exceed $46,800.00.

Awarded contract 75N95025P00042 to LUMINESCENT CONSULTING LLC for 46800.00 on 2024-12-06.

Files

File Type Posted
SSJ Luminescent Redacted.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse Total Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors